Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines

Although it has been demonstrated that certain cytokines, particularly proinflammatory cytokines, can enhance ongoing viral replication in peripheral blood mononuclear cells (PBMCs) of HIV-1–infected individuals, it is unclear what role these cytokines play in the induction of HIV-1 replication in latently infected, resting CD4+ T cells. This study demonstrates that the in vitro combination of the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α together with the immunoregulatory cytokine IL-2 are potent inducers of viral replication in highly purified, latently infected, resting CD4+ T cells derived from HIV-infected individuals who are antiretroviral therapy–naive as well as those who are receiving highly active antiretroviral therapy (HAART). Viral replication induced by this combination of cytokines was completely suppressed in the presence of HAART in vitro. Given that an array of cytokines, including IL-6, TNF-α, and IL-2, are copiously expressed in the microenvironment of the lymphoid tissues, which harbor the latent viral reservoirs, induction of HIV by this combination of cytokines may in part explain the commonly observed reappearance of detectable plasma viremia in HIV-infected individuals in whom HAART was discontinued. Moreover, since it is likely that these infected cells die upon activation of virus and that HAART prevents spread of virus to adjacent cells, the observation that this combination of cytokines can markedly induce viral replication in this reservoir may have important implications for the activation-mediated diminution of the latent reservoir of HIV in patients receiving HAART.

[1]  J. Dayer,et al.  Purified blood monocytes from HIV 1-infected patients induce high levels of TNFα and IL-1 , 1989 .

[2]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[3]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Boucher,et al.  Overshoot of HIV‐1 viraemia after early discontinuation of antiretroviral treatment , 1997, AIDS.

[5]  A. Fauci,et al.  Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1 , 1995, Molecular medicine.

[6]  R. Puri,et al.  Human Cytokines: Their Role in Disease and Therapy , 1995 .

[7]  A. Fauci,et al.  Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. , 1994, Science.

[8]  J. Justement,et al.  Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line. , 1993, AIDS research and human retroviruses.

[9]  A. Fauci,et al.  Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. , 1996, Journal of immunology.

[10]  S. Garbisa,et al.  Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. , 1992, The Journal of infectious diseases.

[11]  E. De Clercq,et al.  Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro. , 1990, Biochemical and biophysical research communications.

[12]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[13]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[14]  P. Roux‐Lombard,et al.  Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. , 1989, Clinical immunology and immunopathology.

[15]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Fauci,et al.  Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. , 1986, Science.

[17]  R. Schleimer,et al.  Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. , 1996, The Journal of allergy and clinical immunology.

[18]  J. Justement,et al.  Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms , 1990, The Journal of experimental medicine.

[19]  A. Fauci,et al.  Cytokine Cascades in HIV Infection , 1996 .

[20]  T. Olsson,et al.  Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[21]  G. Zimmerman,et al.  Endothelial cell interactions with granulocytes: tethering and signaling molecules. , 1992, Immunology today.

[22]  A. Fauci,et al.  HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. , 1995, Journal of immunology.

[23]  N. Yamamoto,et al.  Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. , 1989, Biochemical and biophysical research communications.

[24]  J. Justement,et al.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.

[25]  L. McQuay,et al.  Dilution assay statistics , 1994, Journal of clinical microbiology.

[26]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[27]  A. Hernvann,et al.  Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states , 1994, Clinical and diagnostic laboratory immunology.

[28]  T. Elbeik,et al.  Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.

[29]  A. Fauci,et al.  Cytokine modulation of HIV expression. , 1993, Seminars in immunology.

[30]  M. Rieder,et al.  Regulation of cytokine and cytokine receptor expression by glucocorticoids , 1996, Journal of leukocyte biology.

[31]  A. Fauci,et al.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.

[32]  A. Fauci,et al.  Mechanisms of glucocorticoid action on immune processes. , 1979, Annual review of pharmacology and toxicology.

[33]  A. Fauci,et al.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Chrousos,et al.  The Stress Response and the Regulation of Inflammatory Disease , 1992, Annals of Internal Medicine.

[35]  A. Fauci,et al.  Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? , 1994, Journal of virology.

[36]  M. Ostrowski,et al.  Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. , 1997, AIDS Research and Human Retroviruses.

[37]  A. Fauci,et al.  New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.

[38]  W. O'brien,et al.  Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.

[39]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[40]  C H Fox,et al.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.

[41]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[42]  D. Dormont,et al.  Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replication. , 1994, Research in virology.

[43]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[44]  A. Capron,et al.  Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. , 1989, Clinical and experimental immunology.

[45]  A. Baldwin,et al.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.

[46]  L. Montaner,et al.  Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor , 1996, Journal of virology.

[47]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[48]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.